We are monitoring the impact of COVID-19 on APAC Kidney Cancer Diagnostics and Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 788
Share on
Share on

Asia Pacific Kidney Cancer Diagnostics and Therapeutics Market Research Report - Segmented By Type, Tests & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2019 - 2024)

Pulished: February, 2020
ID: 788
Pages: 138

APAC Kidney Cancer Diagnostics and Therapeutics Market Size & Growth (2019 - 2024)

The size of the Kidney Cancer Diagnostics and Therapeutics Market in Asia-Pacific was worth USD 0.94 billion in 2019 and estimated to be growing at a CAGR of 5.92%, to reach USD 1.25 billion by 2024.

Kidney cancer is one of the frequent urologic tumors accounting for around 3% of all human cancers.

Surgical methods alone are sometimes not enough for the treatment of these cancers, mainly in cases where patients acquire metastatic cancers. This is when supplementary treatment routines are suggested and various factors such as immunotherapies and targeted therapies come into the equation.

The growth of the Asia-Pacific Kidney Cancer Diagnostics and Therapeutics market is mainly due to the rise in the aging population, and increasing awareness towards Kidney Cancer.

However, poor accessibility of proper care, volatile economies and lack of awareness in this part of the world are the key factors hindering the growth of the market in this region.

This research report segmented and sub-segmented into the following categories:

  • By Type: Transitional Cell Cancer, Renal Cell Carcinoma, Renal Sarcoma and Others
  • By Tests: Biopsy, CT Scan, Cystoscopy, Intravenous Pyelogram and Kidney Ultrasound
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

On the basis of test type, the Biopsy and CT Scan lead the tests segment in the Kidney Cancer Diagnostics and Therapeutics market accounting for more than 50% of the market.

The Asia-Pacific Kidney Cancer Diagnostics and Therapeutics market is anticipated to increase at the highest CAGR during the forecast period due to reasons such as rising aging population, increasing awareness, and strong economic growth in countries such as China, Japan, and Australia.

The Top companies leading in the APAC America Kidney Cancer Diagnostics and Therapeutics Market profiled in this report are GlaxoSmithKline, Bayer, Pfizer, Sanofi S.A, Hoffmann La Roche, Novartis and Abbott Laboratories.

1.Introduction                              

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By Type                     

                             5.1.1 Transitional Cell Cancer    

                             5.1.2 Renal cell carcinoma         

                             5.1.3 Renal sarcoma     

                             5.1.4 Other Cancers      

              5.2 By Tests                     

                             5.2.1 Biopsy      

                             5.2.2 CT Scan    

                             5.2.3 Cystoscopy            

                             5.2.4 Intravenous pyelogram    

                             5.2.5 Kidney Ultrasound             

6. Geographical Analysis                                         

              6.1 Introduction                           

              6.2 China                         

              6.3 India                          

              6.4 Japan                         

              6.5 South Korea                            

              6.6 Australia                   

7. Pipeline Product Analysis                                    

              7.1 Overview                                 

              7.2 Pipeline Development Landscape                                 

              7.3 Molecular Targets in the Pipeline                                  

              7.4 Clinical Trials                          

                             7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target    

                             7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target             

                             7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.   

8.Strategic Analysis                                    

              8.1 PESTLE analysis                      

                             8.1.1 Political    

                             8.1.2 Economic

                             8.1.3 Social       

                             8.1.4 Technological       

                             8.1.5 Legal         

                             8.1.6 Environmental     

              8.2 Porter’s Five analysis                          

                             8.2.1 Bargaining Power of Suppliers       

                             8.2.2 Bargaining Power of Consumers   

                             8.2.3 Threat of New Entrants    

                             8.2.4 Threat of Substitute Products and Services             

                             8.2.5 Competitive Rivalry within the Industry     

9.Market Leaders' Analysis                                     

              9.1 GlaxoSmithKline                    

                             9.1.1 Overview 

                             9.1.2 Product Analysis  

                             9.1.3 Strategic Evaluation and Operations          

                             9.1.4 Financial analysis 

                             9.1.5 Legal issues           

                             9.1.6 Recent Developments       

                             9.1.7 SWOT analysis      

                             9.1.8 Analyst View         

              9.2 Bayer                         

              9.3 Pfizer                         

              9.4 Sanofi S.A                 

              9.5 Hoffmann La Roche              

              9.6 Novartis                    

              9.7 Abbott Laboratories                            

10.Competitive Landscape                                      

              10.1 Market share analysis                      

              10.2 Merger and Acquisition Analysis                  

              10.3 Agreements, collaborations and Joint Ventures                    

              10.4 New Product Launches                     

11.Expert Opinions                                    

              11.1 Market Outlook                   

              11.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2019-2024 (USD Billion)
  2. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  3. Asia-Pacific Transitional Cell Cancer Market By Region, From 2019-2024 (USD Billion)
  4. Asia-Pacific Renal cell carcinoma Market By Region, From 2019-2024 (USD Billion)
  5. Asia-Pacific Renal sarcoma Market By Region, From 2019-2024 (USD Billion)
  6. Asia-Pacific Other Kidney Cancers Market By Region, From 2019-2024 (USD Billion)
  7. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  8. Asia-Pacific Biopsy Market By Region, From 2019-2024 (USD Billion)
  9. Asia-Pacific CT Scan Market By Region, From 2019-2024 (USD Billion)
  10. Asia-Pacific Cystoscopy Market By Region, From 2019-2024 (USD Billion)
  11. Asia-Pacific Intravenous pyelogram Market By Region, From 2019-2024 (USD Billion)
  12. Asia-Pacific Kidney Ultrasound Market By Region, From 2019-2024 (USD Billion)
  13. China Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  14. China Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  15. India Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  16. India Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  17. Japan Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  18. Japan Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  19. South Korea Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  20. South Korea Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  21. Australia Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  22. Australia Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample